X @Bloomberg
GSK(US:GSK) Bloombergยท2025-07-17 17:10Regulatory Approval - GSK's blood cancer drug approval is in doubt after failing to secure backing from a US regulatory panel [1] Pharmaceutical Industry - The outcome potentially impacts GSK's market position in the blood cancer drug sector [1]